Concourse Financial Group Securities’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Hold
0
11213
2022
Q3
Hold
0
11025
2022
Q2
Hold
0
10803
2022
Q1
Hold
0
10556
2021
Q4
Hold
0
10095
2021
Q3
Hold
0
9362
2021
Q2
Hold
0
8808
2021
Q1
Hold
0
8187
2020
Q4
Hold
0
7482
2020
Q3
Hold
0
7147
2020
Q2
Hold
0
6935
2020
Q1
Hold
0
6808
2019
Q4
Hold
0
6712
2019
Q3
Hold
0
6546
2019
Q2
Hold
0
6506
2019
Q1
Hold
0
6353
2018
Q4
Hold
0
6268